SA国际传媒

Boost Adoption of Evidence-Based Psychosocial Treatments

SA国际传媒advocates for policies that encourage the uptake of evidence-based psychosocial treatments to improve the lives of people living with addiction. This includes: 

• Contingency management (CM), an intervention in which a patient is given a reward to reinforce positive behaviors associated with addiction treatment or participation. Extensive research shows that CM is the most effective treatment option for stimulant use disorders and represents the current standard of care.

• Adopting integrated delivery care models, such as the Primary Care Behavioral Health Model and Collaborative Care Model, which allow for coordinated care between primary care and behavioral health professionals.

Champion Smart Drug Policy Reforms

Tobacco

SA国际传媒advocates for policies to prevent the use of tobacco products and expand access to treatments for tobacco use disorder. This includes maintaining tobacco fees and eliminating flavored cigars. 

Alcohol

To reduce harms associated with drinking alcohol and alcohol use disorder (AUD), SA国际传媒supports an increase in the federal alcohol excise tax, which has been left untouched since 1991.  

Cannabis

SA国际传媒supports the decriminalization of cannabis possession for personal use, alongside appropriate regulations and oversight to protect public health. Additionally, SA国际传媒supports rescheduling marijuana with lower THC concentrations to Schedule III, with some stipulations, and maintains that higher potency marijuana should remain in Schedule I in the absence of Congressional action. 

 Support Integration of Useful Technologies in Addiction Care

SA国际传媒supports the use of technology to increase access to addiction treatment, including investments to expand the use and sharing of electronic health records (EHRs), the development of digital health technologies, the use of remote patient monitoring, and regulatory guardrails to protect patient privacy and the patient-clinician relationship. SA国际传媒also calls for policies that refocus prescription drug monitoring programs (PDMPs) to serve public health.

As part of this effort, in 2024 SA国际传媒welcomed a final rule promoting partial alignment between 42 CFR Part 2 and the Health Insurance Portability and Accountability Act (HIPAA) while maintaining critical privacy protections.

 Advance Addiction Medicine Research & Development

An unpredictable and ever-changing illicit drug market has made it clear that more tools are needed to combat the overdose crisis and address the prevalence of addiction involving opioids or other substance use. Unfortunately, there has been a concerning lack of research and development within the addiction space when compared to other chronic medical conditions.